Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Spaulding-Labuschagne Neuromodulation Center, Harvard Medical School, Charlestown, Massachusetts, USA.
Am J Hypertens. 2020 Mar 13;33(3):252-260. doi: 10.1093/ajh/hpz181.
To estimate the prevalence and determinants of hypertension in India based on a new definition by the 2017 American College of Cardiology/American Heart Association (2017 ACC/AHA) Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults, and compare prevalence estimates with those of the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC7).
We used the National Family Health Survey (NFHS-4) conducted in India (n = 212,007). We accounted for the sampling strategy by applying survey weights.
Prevalence of hypertension among Indians aged 15-49 years was 40.6% (95% confidence interval [CI]: 40.3-41.0) and 13.0% (95% CI: 12.8-13.2) based on 2017 ACC/AHA and JNC7 guidelines respectively. The overall absolute increase in prevalence was 27.6% (95% CI:27.3-27.9). The absolute changes in crude prevalence of hypertension between the JNC7 and 2017 ACC/AHA guidelines for men and women were 31.4% (95% CI: 30.9-31.9) and 23.7% (95% CI: 23.5-23.9), respectively. As per both guidelines, the overall prevalence was significantly higher among older people, age, male sex, overweight/obesity, higher wealth status, and urban residence.
Applying the 2017 ACC/AHA guideline to the Indian population led to a significant increase in the proportion of Indians with hypertension. There is also socioeconomic differences in the prevalence of hypertension as per both guidelines. Implementation and expansion of public health efforts for prevention and control strategies for hypertension is warranted.
根据 2017 年美国心脏病学会/美国心脏协会(2017 ACC/AHA)高血压预防、检测、评估和管理指南中的新定义,估计印度高血压的患病率及其决定因素,并将患病率估计值与第七次联合国家委员会报告(JNC7)进行比较。
我们使用了在印度进行的全国家庭健康调查(NFHS-4)(n=212007)。我们通过应用调查权重来考虑抽样策略。
根据 2017 ACC/AHA 和 JNC7 指南,15-49 岁印度人的高血压患病率分别为 40.6%(95%置信区间[CI]:40.3-41.0)和 13.0%(95% CI:12.8-13.2)。总体患病率绝对增加了 27.6%(95% CI:27.3-27.9)。JNC7 和 2017 ACC/AHA 指南之间男性和女性高血压粗患病率的绝对变化分别为 31.4%(95% CI:30.9-31.9)和 23.7%(95% CI:23.5-23.9)。根据这两个指南,老年人、男性、超重/肥胖、较高的财富状况和城市居住者的总体患病率均显著较高。
将 2017 ACC/AHA 指南应用于印度人群,导致高血压患者的比例显著增加。根据这两个指南,高血压的患病率也存在社会经济差异。需要实施和扩大公共卫生努力,以预防和控制高血压策略。